Summary

Global Nano Adhesives Market is valued approximately at USD 21.94 billion in 2023 and is anticipated to grow with a healthy CAGR of more than 4.7% over the forecast period 2024-2032. Nano adhesives, formulated with nanoparticles to enhance bond strength, thermal stability, and durability, have carved a pivotal niche in industries that demand precise and high-performance bonding solutions. These microscopic particles drastically alter the interfacial properties of adhesives, facilitating superior adhesion across dissimilar surfaces—critical in sectors like aerospace, electronics, and advanced construction. As global manufacturing trends pivot toward miniaturization, energy efficiency, and material versatility, the demand for nano adhesives is expanding rapidly, underscoring their relevance in next-gen applications such as wearable electronics, lightweight composite aircraft parts, and high-performance structural components.
The proliferation of lightweight materials and the pursuit of energy-efficient production methods are reinforcing the adoption of nano adhesive technologies. Manufacturers in aerospace and automotive domains are increasingly turning to nano-enhanced solutions to replace traditional mechanical fasteners—thereby reducing weight and improving aerodynamics. Concurrently, the electronics industry is leveraging nano adhesives to meet the intricate bonding demands of microchips, touchscreens, and flexible circuitry. The construction sector, too, is embracing nano adhesive innovation, especially in sustainable building envelopes and smart infrastructure, where enhanced weather resistance and longevity are paramount.
Furthermore, ongoing advancements in nanotechnology and material science are enabling the development of tailor-made nano adhesives with customized mechanical, chemical, and thermal properties. These developments are paving the way for smart adhesives that can self-heal, conduct electricity, or change characteristics in response to stimuli—expanding their utility into emerging domains like biomedical devices and responsive textiles. Despite this, challenges remain. High formulation costs, limited large-scale manufacturing infrastructure, and regulatory uncertainty regarding nanoparticle exposure still inhibit broader market penetration, particularly among small and medium enterprises.
Strategic collaborations between chemical giants and tech innovators are increasingly driving the commercialization of novel nano adhesive formulations. Companies are investing in integrated R&D pipelines, intellectual property acquisitions, and pilot production facilities to shorten the innovation-to-market cycle. In addition, rising consumer demand for low-VOC, environmentally friendly adhesives is fueling the rise of bio-based nano adhesive variants. As sustainability becomes a cornerstone of industrial procurement strategies, suppliers are expected to refine their portfolios to align with evolving ESG mandates.
Regionally, North America commands a leading share in the global nano adhesives market, propelled by its robust aerospace and electronics manufacturing ecosystem, in addition to stringent performance standards that favor high-grade materials. Europe follows closely, buoyed by green building initiatives and a strong regulatory framework for industrial adhesives. Meanwhile, the Asia Pacific region is forecasted to experience the fastest growth, attributed to escalating construction activity, booming electronics manufacturing in countries like China and South Korea, and rising investments in research infrastructure. Latin America and the Middle East & Africa also exhibit positive momentum, supported by expanding industrial bases and increasing urbanization.
Major market players included in this report are:
• BASF SE
• Henkel AG & Co. KGaA
• 3M Company
• H.B. Fuller Company
• Arkema Group
• Sika AG
• Dow Inc.
• Covestro AG
• Master Bond Inc.
• Avery Dennison Corporation
• Permabond LLC
• NanoTechLabs Inc.
• Huntsman Corporation
• Dymax Corporation
• Ashland Global Holdings Inc.
The detailed segments and sub-segment of the market are explained below:
By End-use
• Aerospace
• Construction
• Electronics
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global 3D Bioprinting in Medical Market Executive Summary
1.1. Global 3D Bioprinting in Medical Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
 1.3.1. By Products and Solutions (Bioprinters, Consumables and accessories, Software and services)
 1.3.2. By Technology (Extrusion based bioprinting, Inkjet based bioprinting, Laser assisted bioprinting, Others)
 1.3.3. By Application (Tissue engineering and regenerative medicine, Drug discovery and development, Others)
 1.3.4. By End User (Biotechnology and pharmaceutical companies, Academic and research institutes, Others)
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global 3D Bioprinting in Medical Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
 2.3.1. Inclusion & Exclusion
 2.3.2. Limitations
 2.3.3. Supply Side Analysis
  2.3.3.1. Availability
  2.3.3.2. Infrastructure
  2.3.3.3. Regulatory Environment
  2.3.3.4. Market Competition
  2.3.3.5. Economic Viability (Consumer’s Perspective)
 2.3.4. Demand Side Analysis
  2.3.4.1. Regulatory Frameworks
  2.3.4.2. Technological Advancements
  2.3.4.3. Environmental Considerations
  2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global 3D Bioprinting in Medical Market Dynamics
3.1. Market Drivers
 3.1.1. Rising Consumer Shift Toward Preventive Healthcare
 3.1.2. Growing Demand for Personalized Medicine and Advanced Tissue Engineering
 3.1.3. Technological Advancements in Multi-material and Multi-cellular Printing
3.2. Market Challenges
 3.2.1. Stringent Regulatory Approval and Quality Compliance
 3.2.2. Variability in Clinical Efficacy Across Different Strains and Formulations
 3.2.3. High Production Costs and Technological Complexity
3.3. Market Opportunities
 3.3.1. Expansion into New Therapeutic and Diagnostic Applications
 3.3.2. Increasing Adoption by Biotechnology and Pharmaceutical Players
 3.3.3. Growth in Academic and Research Institutional Investments
Chapter 4. Global 3D Bioprinting in Medical Market Industry Analysis
4.1. Porter’s 5 Force Model
 4.1.1. Bargaining Power of Suppliers
 4.1.2. Bargaining Power of Buyers
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
 4.1.6. Futuristic Approach to Porter’s 5 Force Model
 4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
 4.2.1. Political
 4.2.2. Economical
 4.2.3. Social
 4.2.4. Technological
 4.2.5. Environmental
 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global 3D Bioprinting in Medical Market Size & Forecasts by Products and Solutions 2022-2032
5.1. Segment Dashboard
5.2. Global 3D Bioprinting in Medical Market: Products and Solutions Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
 5.2.1. Bioprinters
 5.2.2. Consumables and accessories
 5.2.3. Software and services
Chapter 6. Global 3D Bioprinting in Medical Market Size & Forecasts by Technology 2022-2032
6.1. Segment Dashboard
6.2. Global 3D Bioprinting in Medical Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
 6.2.1. Extrusion based bioprinting
 6.2.2. Inkjet based bioprinting
 6.2.3. Laser assisted bioprinting
 6.2.4. Others
Chapter 7. Global 3D Bioprinting in Medical Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Global 3D Bioprinting in Medical Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
 7.2.1. Tissue engineering and regenerative medicine
 7.2.2. Drug discovery and development
 7.2.3. Others
Chapter 8. Global 3D Bioprinting in Medical Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global 3D Bioprinting in Medical Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
 8.2.1. Biotechnology and pharmaceutical companies
 8.2.2. Academic and research institutes
 8.2.3. Others
Chapter 9. Global 3D Bioprinting in Medical Market Size & Forecasts by Region 2022-2032
9.1. North America 3D Bioprinting in Medical Market
 9.1.1. U.S. 3D Bioprinting in Medical Market
  9.1.1.1. Products and Solutions Breakdown Size & Forecasts, 2022-2032
  9.1.1.2. End User Breakdown Size & Forecasts, 2022-2032
 9.1.2. Canada 3D Bioprinting in Medical Market
9.2. Europe 3D Bioprinting in Medical Market
 9.2.1. UK 3D Bioprinting in Medical Market
 9.2.2. Germany 3D Bioprinting in Medical Market
 9.2.3. France 3D Bioprinting in Medical Market
 9.2.4. Spain 3D Bioprinting in Medical Market
 9.2.5. Italy 3D Bioprinting in Medical Market
 9.2.6. Rest of Europe 3D Bioprinting in Medical Market
9.3. Asia Pacific 3D Bioprinting in Medical Market
 9.3.1. China 3D Bioprinting in Medical Market
 9.3.2. India 3D Bioprinting in Medical Market
 9.3.3. Japan 3D Bioprinting in Medical Market
 9.3.4. Australia 3D Bioprinting in Medical Market
 9.3.5. South Korea 3D Bioprinting in Medical Market
 9.3.6. Rest of Asia Pacific 3D Bioprinting in Medical Market
9.4. Latin America 3D Bioprinting in Medical Market
 9.4.1. Brazil 3D Bioprinting in Medical Market
 9.4.2. Mexico 3D Bioprinting in Medical Market
 9.4.3. Rest of Latin America 3D Bioprinting in Medical Market
9.5. Middle East & Africa 3D Bioprinting in Medical Market
 9.5.1. Saudi Arabia 3D Bioprinting in Medical Market
 9.5.2. South Africa 3D Bioprinting in Medical Market
 9.5.3. Rest of Middle East & Africa 3D Bioprinting in Medical Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
 10.1.1. 3D Systems Corporation
 10.1.2. Desktop Metal, Inc.
 10.1.3. Organovo Holdings, Inc.
10.2. Top Market Strategies
10.3. Company Profiles
 10.3.1. 3D Systems Corporation
  10.3.1.1. Key Information
  10.3.1.2. Overview
  10.3.1.3. Financial (Subject to Data Availability)
  10.3.1.4. Product Summary
  10.3.1.5. Market Strategies
 10.3.2. Cyfuse Biomedical K.K.
 10.3.3. Medprin Biotech GmbH.
 10.3.4. Advanced Solutions, Inc.
 10.3.5. CollPlant Biotechnologies Ltd.
 10.3.6. REGEMAT 3D S.L.
 10.3.7. The Bio Convergence Company
 10.3.8. Shining 3D
Chapter 11. Research Process
11.1. Research Process
 11.1.1. Data Mining
 11.1.2. Analysis
 11.1.3. Market Estimation
 11.1.4. Validation
 11.1.5. Publishing
11.2. Research Attributes